Company
CathVision
CathVision is committed to enhancing clinical decision making and patient outcomes in the EP lab through the advancement of EP recording technologies.
- Status
- Operatingas of 2026-09-22
- Business model
- B2B
- Headquarters
- Minnesota, United States
- Founded
- 2010
- Customers
- electrophysiologists
- Legal name
- CathVision ApS
- cathvision.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 22 September 2026
About
CathVision’s mission is to help physicians cure cardiac arrhythmia. Committed to empowering physicians to make more informed clinical decisions in the EP lab, CathVision is redefining the necessity of exceptional cardiac electrical signals to diagnose, characterize and treat the most common heart rhythm disorders. The company is focused on developing electrophysiology solutions centered around an innovative EP recording system and AI-based analytic tools.
Funding snapshot
- Total raised
- $9MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Undisclosed, $9M2023-07-30
Funding rounds
- Round, 2023
- $9M2023-07-30, Company stated
Products
- Other
- CARDIALYTICS
- Hardware
- ECGenius System
Loading relationship preview